All stock reports

RVHL evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-29T23:41:35.909511+00:00

Metrics

latest_annual_period
2026-03-31
revenue
815562000.0
net_income
488910000.0
operating_cash_flow
407961000.0
free_cash_flow
294405000.0
total_assets
3247470000.0
total_liabilities
348257000.0
total_equity
2899213000.0
cash
464696000.0
total_debt
10000000.0
revenue_growth
141.33193717277487
earnings_growth
-20.268148498462995
net_margin
0.5994761894252062
roe
0.16863541933621295
debt_to_equity
0.0034492119068174707
cash_conversion
0.834429649628766
free_cash_flow_margin
0.36098420475696513
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Evidence unavailable. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-9b5a2b17179c251d167ed82a8b3e6879a271028a9697c7d29d52f16b4d77a7b4
Policy
stock-decisions-v1
Evidence bundle hash
a952cb05559016d3f84ab0b2a175813406f8c6fcadbd299dd03a4a647d4dc52d
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 4e8dd71775e1b24d12966f9676dcef0bf11b92bb1d05a7094862eadafe92a332
  • daily-price: 130796c26b27c8da5722e87723c951c55a86b516fe51f9cba84843bac823fe06
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits